Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

Front Pharmacol. 2023 May 25:14:1220144. doi: 10.3389/fphar.2023.1220144. eCollection 2023.

Authors

Xing Wang^{1

2}, Guobing Yin¹, Wei Zhang², Kunling Song², Longbin Zhang², Zufeng Guo²

Affiliations

¹ Department of Breast and Thyroid Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Center for Novel Target and Therapeutic Intervention, Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.717730.].

Keywords: PTGR1; cancer therapeutics; eicosanoid pathways; inhibitor; tumor metabolism.

Copyright © 2023 Wang, Yin, Zhang, Song, Zhang and Guo.

Publication types

Published Erratum